Intravesical resiniferatoxin for the treatment of detrusor hyperreflexia refractory to capsaicin in patients with chronic spinal cord diseases

Scandinavian Journal of Urology and Nephrology

Volumn 32, Issue 5, 1998, Pages 331-334

  Lazzeri, Massimo ^a,c   Spinelli, Michele ^b   Beneforti, Patrizia ^a   Zanollo, Alberto ^b   Turini, Damiano ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b Spinal Unit   (Italy)

^c NONE   (Italy)

Author keywords

Capsaicin; Detrusor hypereflexia; Resiniferatoxin; Sensory neurons

Indexed keywords

CAPSAICIN; RESINIFERATOXIN;

ABDOMINAL PRESSURE; ADULT; ARTICLE; BLADDER FUNCTION; CATHETERIZATION; CHRONIC DISEASE; CLINICAL ARTICLE; CYSTOMETRY; DESENSITIZATION; DETRUSOR DYSSYNERGIA; DRUG EFFECT; DRUG ISOLATION; FEMALE; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; SPINAL CORD DISEASE; URODYNAMICS;

ADMINISTRATION, INTRAVESICAL; ADULT; CAPSAICIN; DITERPENES; FEMALE; HUMANS; MALE; NEUROTOXINS; REFLEX, ABNORMAL; SPINAL CORD DISEASES; TIME FACTORS; URINARY BLADDER; URINARY BLADDER, NEUROGENIC; URODYNAMICS;

EID: 0031786527     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655998750015287     Document Type: Article

References (14)

1. de Groat WC, Kawatani M, Hisamitsu T, Cheng CL, Ma CP, Thor K, et al. Mechanisms underlying the recovery of urinary bladder function following spinal cord injury. J Auton Nerv Syst 1990; Suppl 30: S71.
2. Fowler CJ, Jewkes D, McDonald WI, Lynn B, de Groat WC. Intravesical capsaicin for neurogenic bladder dysfunction [letter]. Lancet 1992; 339: 1239.
3. Fowler CJ, Beck RO, Gerrard S, Betts CD, Fowler CG. Intravesical capsaicin for the treatment of detrusor hyperreflexia. J Neurol Neurosurg Psychiatry 1994; 57: 169.
4. Chandiramani VA, Peterson T, Duthie GS, Fowler CJ. Urodynamic changes during therapeutic intravesical instillations of capsaicin. Br J Urol 1996; 77: 792.
5. Lazzeri M, Beneforti P, Turini D. Urodynamic effects of intravesical resiniferatoxin in humans. J Urol 1997; 157 (Suppl): 104.
6. Abrams P, Blaivas JG, Stanton SL, Andersen JT. Standardization of terminology of lower urinary tract function. International Continence Society Committee on Standardization of Terminology. Neurourol Urodyn 1988; 7: 403.
7. Ishizuka O, Mattiasson A, Andersson KE. Urodynamic effects of intravesical resiniferatoxin and capsaicin in conscious rats with and without outflow obstruction. J Urol 1995; 154: 611.
8. Craft R, Carlisi VJ, Mattia A, Herman RM, Porreca F. Behavioural characterization of the excitatory and desensitizing effects of intravesical capsaicin and resiniferatoxin in the rat. Pain 1993; 55: 205.
9. Szolcsanyi J, Szallasi A, Szallasi Z, Joo F, Blumberg PM. Resiniferatoxin: an ultrapotent selective modulator of capsaicin-sensitive primary afferent neurons. J Pharmacol Exp Ther 1990; 255: 923.
10. Szallasi A, Blumberg PM. Resiniferatoxin and analogs provide novel insights into the pharmacology of the vanilloid receptor. Life Sci 1990; 47: 1399.
11. Szallasi A, Conte B, Goso C, Blumberg PM, Manzini S. Vanilloid receptors in the urinary bladder: regional distribution, localization on sensory nerves and species-related differences. Naunyn Schmiedebergs Arch Pharmacol 1993; 347: 624.
12. Szallasi A. Autoradiographic visualization and pharmacological characterization of vanilloid (capsaicin) receptors in several species, including men. Acta Physiol Scand 1995; Suppl 6: 629.
13. Szallasi A. The vanilloid receptor. In: Geppetti P, Holzer P, editors. Neurogenic inflammation. New York: CRC, 1996: 43-52.
14. Maggi CA, Barbanti G, Santicioli P, Beneforti P, Misuri D, Meli A, et al. Cystometric evidence that capsaicin-sensitive nerves modulate the afferent branch of micturition reflex in humans. J Urol 1989; 142: 150.